Jeffrey H Burbank
CIK 1341411 · Chief Executive Officer · last filed 2026-05-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NXTM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
439 SOUTH UNION STREET 5TH FLOOR
LAWRENCE, MA 01843
Holdings By Company
Recent Filings · Page 7 of 11
105 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-11-20 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | +23,868 | $130.6K | EDGAR |
| 2013-03-12 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | +5,662 | -$30.2K | EDGAR |
| 2013-03-06 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | +25,020 | -$133.5K | EDGAR |
| 2013-03-05 | NxStage Medical, Inc. (NXTM) Delisted | Tax (F) | −3,274 | -$36.2K | EDGAR |
| 2013-01-11 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | +57,412 | -$17.9K | EDGAR |
| 2013-01-03 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | +57,412 | -$17.9K | EDGAR |
| 2012-09-12 | NxStage Medical, Inc. (NXTM) Delisted | Exer (M) | +37,000 | $316.4K | EDGAR |
| 2012-07-13 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −5,000 | -$209.7K | EDGAR |
| 2012-06-21 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −5,000 | -$221.3K | EDGAR |
| 2012-05-25 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −5,000 | -$194.2K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).